Phase I trial of weekly docetaxel, weekly doxorubicin, daily oral cyclophosphamide, and G-CSF (ConTAC Regimen)in advanced malignancies

By Wesolowski Robert   Peereboom David   Weiss Patricia   Elson Paul   Thomas Budd George  

Investigational New Drugs, Vol. 28, Iss. 4, 2010-08 ,pp. : 502-508

Springer Publishing Company

Access to resources Recommend Favorite

Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors

By Vidal Laura  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 616-628

Springer Publishing Company

Access to resources Recommend Favorite

Phase I clinical trial of lenalidomide in combination with temsirolimus in patients with advanced cancer

By Ganesan Prasanth   Piha-Paul Sarina   Naing Aung   Falchook Gerald   Wheler Jennifer   Janku Filip   Zinner Ralph   Laday Shell   Kies Merrill   Tsimberidou Apostolia  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1505-1513

Springer Publishing Company

Access to resources Recommend Favorite

Phase I clinical trial of lenalidomide in combination with sorafenib in patients with advanced cancer

By Ganesan Prasanth   Piha-Paul Sarina   Naing Aung   Falchook Gerald   Wheler Jennifer   Fu Siqing   Hong David   Kurzrock Razelle   Janku Filip   Laday Shell   Bedikian Agop   Kies Merrill   Wolff Robert   Tsimberidou Apostolia  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 279-286

Springer Publishing Company

Access to resources Recommend Favorite

Phase I Clinical Trial of Exherin (ADH-1) in Patients with Advanced Solid Tumors

By  

Current Clinical Pharmacology, Vol. 8, Iss. 1, 2013-02 ,pp. : 81-88

Bentham Science Publishers

Access to resources Recommend Favorite